Filippi M, Grimaldi L, Conte A, Totaro R, et al. Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study. J Neurol 2023 Sep 16. doi: 10.1007/s00415-023-11955.
PMID: 37715789